Effect of cytochrome P450 (CYP) 3A4*1G polymorphism on tacrolimus pharmacokinetics, CYP3A5 mRNA expression level and probability of acute cellular rejection.
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 28 Dec 2015 New trial record